Hip Arthritis, Hip Arthropathy, Hip Dysplasia, Hip Fractures, Hip Necrosis, Hip Osteoarthritis
Conditions
Brief summary
EUROSCUP Fixe is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSCUP Fixe performances and safety
Detailed description
Post market observational study. This study is retropective and prospective, non comparative.
Interventions
DEVICEHip arthroplasty
Hip prosthesis surgical implantation
Sponsors
EUROS
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Inclusion criteria
* Patient who received EUROSCUP Fixe. * Patient informed of its participation to the study * Patient aged between 18 and 80 years old (\<80).
Exclusion criteria
* Patient presenting a contraindication to EUROSCUP Fixe implantation. * Patient who refused to participate to the study * Vulnerable subjects
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Safety of EUROSCUP Fixe | 1 year | Collect the safety of the device trought complications occurence rate |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Clinical performances of EUROSCUP Fixe | 1 year | Collect the performances of the device trought clinical scores |
| Radiological performances of EUROSCUP Fixe | 1 year | Collect the performances of the device trought radiological evaluation |
| Survival of EUROSCUP Fixe | 10 years | Assess the survival rate of the device |
Countries
France
Outcome results
None listed